FLT3 and acute myeloid leukemia: Palma and his colleagues reported an anti-leukaemic role for miR-155 in human FLT3-wildtype AML, by initiating cell apoptosis and myelomonocytic differentiation, which is in contrast to its previously suggested role as an oncogene.